Aytu BioPharma (AYTU) SEC Filings & 10K Form

$2.92
+0.08 (+2.82%)
(As of 11:44 AM ET)

Recent Aytu BioPharma SEC Filings

DateFilerForm TypeView
04/02/2024
3:44 PM
Aytu BioPharma (Issuer)
PYSZCZYMUKA GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
3:37 PM
Aytu BioPharma (Issuer)
PYSZCZYMUKA GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2023
3:05 PM
Aytu BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/26/2023
7:05 AM
Aytu BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/12/2023
1:50 PM
Aytu BioPharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
10/06/2023
3:30 PM
Aytu BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2023
3:37 PM
Aytu BioPharma (Issuer)
PYSZCZYMUKA GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
3:15 PM
Aytu BioPharma (Filer)
Form NT 10-K
09/27/2023
3:20 PM
Aytu BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/18/2023
5:27 PM
Aytu BioPharma (Issuer)
JAIN ABHINAV (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
7:57 PM
Aytu BioPharma (Issuer)
Disbrow Jarrett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
6:44 PM
Aytu BioPharma (Issuer)
LIU VIVIAN H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
6:49 PM
Aytu BioPharma (Issuer)
JAIN ABHINAV (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
6:34 PM
Aytu BioPharma (Issuer)
Disbrow Joshua R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
6:38 PM
Aytu BioPharma (Issuer)
DOCKERY CARL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
6:39 PM
Aytu BioPharma (Issuer)
Donofrio John Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
6:21 PM
Aytu BioPharma (Issuer)
PYSZCZYMUKA GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
6:28 PM
Aytu BioPharma (Issuer)
Oki Mark K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
6:30 PM
Aytu BioPharma (Issuer)
BROOKE CHRISTOPHER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2023
7:05 AM
Aytu BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2023
7:05 AM
Aytu BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/06/2023
2:26 PM
Aytu BioPharma (Issuer)
PYSZCZYMUKA GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:54 PM
Aytu BioPharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/22/2023
3:05 PM
Aytu BioPharma (Issuer)
Harkey Wilmot B. (Reporting)
Mack Daniel (Reporting)
Nantahala Capital Management, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/20/2023
7:35 AM
Aytu BioPharma (Issuer)
PYSZCZYMUKA GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
7:29 AM
Aytu BioPharma (Issuer)
PYSZCZYMUKA GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
4:14 PM
Aytu BioPharma (Subject)
Nantahala Capital Management, LLC (Filed by)
Form SC 13D/A
06/16/2023
3:48 PM
Aytu BioPharma (Subject)
Stonepine Capital Management, LLC (Filed by)
Form SC 13G
06/15/2023
12:52 PM
Aytu BioPharma (Issuer)
Disbrow Joshua R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
9:42 AM
Aytu BioPharma (Issuer)
JAIN ABHINAV (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/09/2023
7:10 AM
Aytu BioPharma (Subject)
Form FWP
06/08/2023
11:15 PM
Aytu BioPharma (Filer)
Form EFFECT
06/05/2023
4:24 PM
Aytu BioPharma (Filer)
Form S-1/A
05/26/2023
12:52 PM
Aytu BioPharma (Subject)
Nantahala Capital Management, LLC (Filed by)
Form SC 13D
05/22/2023
7:00 AM
Aytu BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2023
7:58 AM
Aytu BioPharma (Filer)
Form CT ORDER
05/01/2023
4:20 PM
Aytu BioPharma (Filer)
Form S-1
Registration statement under Securities Act of 1933  
05/01/2023
7:05 AM
Aytu BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2023
7:05 AM
Aytu BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:AYTU) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners